88 related articles for article (PubMed ID: 3334991)
1. Induction of S 100 protein by 5-bromo-2'-deoxyuridine in human neuroblastoma cell lines.
Tsunamoto K; Todo S; Imashuku S; Kato K
Cancer Res; 1988 Jan; 48(1):170-4. PubMed ID: 3334991
[TBL] [Abstract][Full Text] [Related]
2. Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine.
Sugimoto T; Kato T; Sawada T; Horii Y; Kemshead JT; Hino T; Morioka H; Hosoi H
Cancer Res; 1988 May; 48(9):2531-7. PubMed ID: 2833349
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
4. 5-Bromo-2'-deoxyuridine induces S 100 protein in human neuroblastoma cells in culture.
Tsunamoto K; Imashuku S; Hibi S; Esumi N; Kato K
Prog Clin Biol Res; 1988; 271():327-36. PubMed ID: 3406006
[No Abstract] [Full Text] [Related]
5. Morphological differentiation of human neuroblastoma cell lines by a new synthetic polyprenoic acid (E5166).
Sugimoto T; Sawada T; Matsumura T; Horii Y; Kemshead JT; Suzuki Y; Okada M; Tagaya O; Hino T
Cancer Res; 1987 Oct; 47(20):5433-8. PubMed ID: 2820569
[TBL] [Abstract][Full Text] [Related]
6. Procoagulant activity of human neuroblastoma cell lines, in relation to cell growth, differentiation and cytogenetic abnormalities.
Esumi N; Imashuku S; Tsunamoto K; Todo S; Misawa S; Goto T; Fujisawa Y
Jpn J Cancer Res; 1989 May; 80(5):438-43. PubMed ID: 2502520
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
Krajewski S; Chatten J; Hanada M; Reed JC
Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
[TBL] [Abstract][Full Text] [Related]
8. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines.
Cohen PS; Letterio JJ; Gaetano C; Chan J; Matsumoto K; Sporn MB; Thiele CJ
Cancer Res; 1995 Jun; 55(11):2380-6. PubMed ID: 7757990
[TBL] [Abstract][Full Text] [Related]
9. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
[TBL] [Abstract][Full Text] [Related]
10. Human neuroblastoma GOTO cells express CD44 and localize it into lipid rafts upon differentiation into Schwannian cells.
Hasegawa G; Minami N; Kushida A; Inuyama H; Koga M; Wakabayashi K; Saito Y
Cell Biol Int; 2005 Mar; 29(3):193-202. PubMed ID: 15878294
[TBL] [Abstract][Full Text] [Related]
11. NUB-7: a stable I-type human neuroblastoma cell line inducible along N- and S-type cell lineages.
Dimitroulakos J; Squire J; Pawlin G; Yeger H
Cell Growth Differ; 1994 Apr; 5(4):373-84. PubMed ID: 8043511
[TBL] [Abstract][Full Text] [Related]
12. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
de Torres C; Beleta H; Díaz R; Toran N; Rodríguez E; Lavarino C; García I; Acosta S; Suñol M; Mora J
Cancer; 2009 Jun; 115(12):2792-803. PubMed ID: 19350667
[TBL] [Abstract][Full Text] [Related]
13. Forskolin induction of S-100 protein in glioma and hybrid cells.
Higashida H; Sano M; Kato K
J Cell Physiol; 1985 Jan; 122(1):39-44. PubMed ID: 4038402
[TBL] [Abstract][Full Text] [Related]
14. [Differentiation induction and potentiation of chemotherapy by PGE1 infusion in patients with neuroblastoma--effect of PGE1 on metastatic potential of neuroblastoma].
Imashuku S; Esumi N; Todo S; Nakajima F
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):775-80. PubMed ID: 6585182
[TBL] [Abstract][Full Text] [Related]
15. Human neuroblastoma I-type cells are malignant neural crest stem cells.
Ross RA; Spengler BA; Domènech C; Porubcin M; Rettig WJ; Biedler JL
Cell Growth Differ; 1995 Apr; 6(4):449-56. PubMed ID: 7794812
[TBL] [Abstract][Full Text] [Related]
16. Induction of the regulatory subunit of type I adenosine cyclic 3':5'-monophosphate-dependent protein kinase in differentiated N-18 mouse neuroblastoma cells.
Liu AY; Chan T; Chen KY
Cancer Res; 1981 Nov; 41(11 Pt 1):4579-87. PubMed ID: 6272981
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of human neuroblastoma cell lines in their proliferative responses to basic FGF, NGF, and EGF: correlation with expression of growth factors and growth factor receptors.
Janet T; Lüdecke G; Otten U; Unsicker K
J Neurosci Res; 1995 Apr; 40(6):707-15. PubMed ID: 7629887
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta 1 differentially regulates proliferation, morphology, and extracellular matrix expression by three neural crest-derived neuroblastoma cell lines.
Rogers SL; Cutts JL; Gegick PJ; McGuire PG; Rosenberger C; Krisinski S
Exp Cell Res; 1994 Apr; 211(2):252-62. PubMed ID: 8143771
[TBL] [Abstract][Full Text] [Related]
19. Soluble integrin ligands and growth factors independently rescue neuroblastoma cells from apoptosis under nonadherent conditions.
Bozzo C; Bellomo G; Silengo L; Tarone G; Altruda F
Exp Cell Res; 1997 Dec; 237(2):326-37. PubMed ID: 9434628
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta regulates differentiation and proliferation of human neuroblastoma.
Scarpa S; Coppa A; Ragano-Caracciolo M; Mincione G; Giuffrida A; Modesti A; Colletta G
Exp Cell Res; 1996 Nov; 229(1):147-54. PubMed ID: 8940258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
